Rick Winningham | Chairman and Chief Executive Officer |
Rhonda Farnum | Senior Vice President, Chief Business Officer |
Rick Graham | Senior Vice President, Research and Development |
Andrew Hindman | Chief Financial Officer |
Eva Privitera | Cowen |
Douglas Tsao | H.C. Wainwright |
Joseph Stringer | Needham |
Brian Skorney | Baird |
David Risinger | SVB Securities |
Ladies and gentlemen, good afternoon. I would like to welcome everyone to the Theravance Biopharma Third Quarter 2022 Conference Call.
During the presentation all participants will be in a listen-only mode. A question-and-answer session will follow the Company's formal remarks. [Operator Instructions] Also today's conference call is being recorded.